ACM
GTHX

Aquatic Capital Management’s G1 Therapeutics, Inc. Common Stock GTHX Stock Holding History

Aquatic Capital Management’s Portfolio GTHX Stock Details GTHX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-2,000
Closed -$11K – 1848
2022
Q4 		$11K Sell
2,000
-2,100
-51% -$17.6K ﹤0.01% 1216
2022
Q3 		$51K Sell
4,100
-4,700
-53% -$53.7K 0.01% 880
2022
Q2 		$43K Buy
8,800
+7,400
+529% +$41K 0.01% 687
2022
Q1 		$11K Buy
+1,400
New +$13.3K 0.02% 650

Other funds holding GTHX

Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Marshall Wace
Marshall Wace London, United Kingdom $100B AUM 35.1% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Aquatic Capital Management's GTHX Position: Q1 2023 in Review

Aquatic Capital Management sold out of G1 Therapeutics, Inc. Common Stock (GTHX) in Q1 2023, closing a stake of 2,000 shares — an estimated $11K sold.

Aquatic Capital Management first reported a position in GTHX in Q1 2022 and held it in 4 quarters. The position peaked at $51K in Q3 2022. 96 funds tracked by Wall St. Rank hold GTHX as of Q1 2023.

  • Aquatic Capital Management reported no remaining G1 Therapeutics, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Aquatic Capital Management sold 2,000 G1 Therapeutics, Inc. Common Stock shares in Q1 2023, an estimated $11K.
  • Aquatic Capital Management first reported a position in G1 Therapeutics, Inc. Common Stock in Q1 2022 and held it in 4 quarters.
  • Aquatic Capital Management's G1 Therapeutics, Inc. Common Stock position peaked at $51K in Q3 2022.
  • 96 funds tracked by Wall St. Rank held G1 Therapeutics, Inc. Common Stock as of Q1 2023.

Based on Aquatic Capital Management's 13F filing for Q1 2023, filed 15 May 2023.